TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02166229

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“No subjects were enrolled.”

The sponsor’s own words in the registry.

Life of this trial

2014201520162017Registered2014-06-10Planned start2014-06 (planned)Withdrawn (as of)2016-08-11

Vital statistics

Status
Withdrawn
Phase
Phase 1, Phase 2
Sponsor
Yale University
Sponsor type
University, hospital or other
Conditions
Scleroderma; Systemic Sclerosis
Interventions
Divalproex sodium
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.